Clinical Exercise Prescription Tool for Mental Health
A decision-support tool for clinicians to prescribe specific physical activity dosages as adjunctive treatments for ADHD, depression, and schizophrenia. The tool integrates evidence-based activity guidelines with adherence strategies to improve patient outcomes and medication stability.
Concept
Instead of general advice to 'be active,' this tool provides clinicians with evidence-based 'prescriptions' for physical activity tailored to specific mental health diagnoses. It suggests specific activity types and intensities known to improve attention in ADHD patients or reduce depressive symptoms in adults, integrating behavioral change techniques to ensure patient adherence.
Why now
Research [0] synthesizes 13 high-quality meta-analyses and 256 RCTs, providing a clear evidence base for the efficacy of physical activity as an adjunctive treatment, particularly for ADHD attention and depressive symptoms.
Crucially, new evidence [1] highlights the systemic challenge of adherence in psychiatric populations, noting that adherence rates for medication in schizophrenia and bipolar disorder can be as low as 35-60%. This suggests that a 'prescription' for exercise cannot exist in a vacuum; it must be integrated into a broader adherence framework. Because non-adherence in mental health is strongly linked to increased hospitalization and dangerous behavior, the tool's value proposition shifts from merely providing 'dosage' to providing a structured support system. By addressing lifestyle barriers and integrating with the patient's overall care plan—similar to the pharmacist-assisted clinic model—the tool can help mitigate the risks associated with the general tendency toward non-adherence in these populations.
Written by Gemma 4 · 1 Oct 2026 · revised 1× with new research (latest 1 Oct 2026, Gemma 4)
AI assessment
A focused clinical decision-support tool that transforms vague exercise advice into precise, evidence-based prescriptions for psychiatric patients, addressing the critical gap between clinical efficacy and patient adherence.
- Evidence strength 5/5
- The idea is strongly grounded in a high-quality meta-review of 256 RCTs for efficacy and a pilot study highlighting the specific adherence failures in psychiatric populations.
- Market pull 4/5
- Health systems like the NHS and Mayo Clinic have high incentives to reduce psychiatric hospitalizations, which the supporting research explicitly links to poor adherence.
- Novelty & moat 3/5
- While exercise prescription isn't new, the specific application of 'dosage' for psychiatric diagnoses combined with a structured adherence framework provides a defensible clinical edge.
- Feasibility 5/5
- The MVP is essentially a structured knowledge base and a tracking interface, requiring no complex hardware or breakthrough biotech to demonstrate value.
- Wedge clarity 4/5
- The focus on 'prescribing' specific activity dosages for ADHD and depression provides a clear, actionable entry point for clinicians.
- Simplicity / focus 5/5
- The product is a single, sharp tool for clinicians rather than an over-scoped wellness platform for patients.
Scored by Gemma 4 · 1 Oct 2026. Rated against a fixed rubric (evidence, market, novelty, feasibility, wedge, simplicity). A prior estimate to compare ideas before real-world signal arrives.
Persona discussion
AI personas trained on real people's expertise debate this idea as it evolves.
View the discussion →Act on this idea
Ideas only matter if someone runs with them. Your message goes straight to the founder's inbox — nothing is stored on our servers.
Business analysis
The PESTEL analysis reveals a strong alignment with current healthcare priorities regarding holistic mental health and digital transformation, though it faces significant hurdles in patient adherence and strict medical liability. The tool's success depends on integrating into existing clinical workflows rather than acting as a standalone prescription service.
Political2
Economic3
Social2
Technological2
Environmental2
Legal3
The success of a clinical tool depends heavily on healthcare regulations, medical guidelines, and the social acceptance of exercise as a formal psychiatric treatment. · Generated 2026-10-01 by Gemma 4AI-generatedFull PESTEL Analysis →
Who benefits
- Mayo Clinicorganization
As a leading healthcare provider, they can integrate evidence-based adjunctive treatments into their integrated care models to improve patient outcomes in psychiatry.
- Psychiatristsindividual
Provides them with a validated framework to recommend physical activity without having to manually synthesize vast amounts of research.
- National Health Service (NHS)organization
Can use the tool to standardize the delivery of adjunctive physical activity treatments across primary care to reduce the burden of depressive and anxiety disorders.
Research it builds on
- The efficacy, mechanisms and implementation of physical activity as an adjunctive treatment in mental disorders: a meta‐review of outcomes, neurobiology and key determinantsDavy Vancampfort, Joseph Firth, Brendon Stubbs et al. · 2025 · 89 citationsAll ideas from this paper →
- The impact of a pharmacist assisted clinic upon medication adherence and quality of life in mental health patientsMitsi H. Lizer · 2013 · 23 citationsAll ideas from this paper →